Chimeric Antigen Receptor T-Cell Therapy Is Associated with Low Absolute Rates of Orofacial Adverse Events and Significantly Less When Compared to Hemopoietic Stem Cell Therapy.

Researchers analysed orofacial adverse events in over 1100 CAR-T therapy recipients and found low rates of oral complications like stomatitis and mucositis, significantly lower than those observed following hematopoietic stem cell transplant.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.